- The BMJ Today: Read our daily selectionof new articles, blogs, responses, audio, and video to appear online
- The BMJ iPad app brings you the best of print and online, including live links to the latest news, blogs, video, and podcasts. Get the BMJ iPad app.
- Our online table of contents is updated at least twice each day. Read all articles published in the last 7 days.
Recent rapid responses
Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window.
Displaying 1-1 out of 1 published
22 December 2012
Also in the EU differences between generic medicinal products and their originators exist. Many older products have several originators in various memberstates and often the product informations are not harmonised. These differences naturally extend to their generics.
Another reason is data protection. If the originator gets an additional indication approved, this is protected and the new indication must not be listed in the product information. This is unfortunately also the case for safety-information generated during this so called line-extension. There are situations where this is appropriate, eg. in case of higher doses for particular indications. Often this is legally required nonsense.
Competing interests: None declared
Austrian Medicines and Medical Devices Agency, Traisengasse 5, 1200 Vienna, Austria
Click to like: